Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Christopher Wardell

Concepts (266)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
39
2025
2999
1.970
 Why?
Mutation
21
2022
1318
1.650
 Why?
High-Throughput Nucleotide Sequencing
5
2021
174
0.960
 Why?
Translocation, Genetic
14
2021
265
0.930
 Why?
Whole Body Imaging
1
2025
25
0.910
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2025
40
0.900
 Why?
Image Processing, Computer-Assisted
1
2025
239
0.820
 Why?
Bone and Bones
1
2025
492
0.690
 Why?
Oncogenes
2
2018
60
0.690
 Why?
Tomography, X-Ray Computed
1
2025
1148
0.620
 Why?
Biliary Tract Neoplasms
1
2018
5
0.560
 Why?
Cholangiocarcinoma
1
2018
26
0.560
 Why?
Gene Expression Profiling
14
2022
1101
0.550
 Why?
Genomics
8
2022
265
0.530
 Why?
Proto-Oncogene Proteins B-raf
3
2022
77
0.500
 Why?
Gene Expression Regulation, Neoplastic
11
2022
853
0.490
 Why?
Prognosis
15
2021
2093
0.400
 Why?
Brain Neoplasms
3
2023
287
0.380
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2020
1020
0.370
 Why?
Gene Dosage
5
2020
76
0.370
 Why?
Humans
52
2025
52114
0.370
 Why?
Genetic Predisposition to Disease
5
2018
528
0.360
 Why?
Plasma Cells
4
2021
234
0.350
 Why?
Genome, Human
4
2021
121
0.340
 Why?
Evolution, Molecular
2
2021
95
0.340
 Why?
Liver Neoplasms
3
2022
332
0.330
 Why?
DNA Mutational Analysis
7
2020
179
0.320
 Why?
Thalidomide
5
2019
377
0.320
 Why?
DNA Copy Number Variations
4
2021
117
0.310
 Why?
In Situ Hybridization, Fluorescence
11
2023
262
0.300
 Why?
Software
2
2021
280
0.290
 Why?
Monoclonal Gammopathy of Undetermined Significance
4
2017
120
0.280
 Why?
Neoplasm Recurrence, Local
3
2021
630
0.270
 Why?
Aged
16
2025
10142
0.270
 Why?
Chromosome Aberrations
6
2022
295
0.260
 Why?
Carcinoma, Hepatocellular
2
2022
199
0.260
 Why?
Middle Aged
18
2025
13028
0.260
 Why?
Polymorphism, Single Nucleotide
3
2018
504
0.250
 Why?
Male
26
2025
26652
0.250
 Why?
Female
27
2025
28055
0.250
 Why?
Epigenesis, Genetic
4
2018
401
0.240
 Why?
Clonal Evolution
2
2019
59
0.240
 Why?
Chromosomes, Human, Pair 1
2
2019
95
0.240
 Why?
Immunoglobulin Heavy Chains
3
2014
46
0.230
 Why?
Neoplasm Proteins
3
2017
328
0.230
 Why?
Disease Progression
8
2021
866
0.220
 Why?
Gene Regulatory Networks
2
2022
111
0.210
 Why?
Lymphoma, B-Cell, Marginal Zone
1
2023
24
0.200
 Why?
Polycomb Repressive Complex 2
2
2021
48
0.200
 Why?
Chromosomes, Human, Pair 14
5
2014
75
0.200
 Why?
Central Nervous System Neoplasms
1
2023
69
0.190
 Why?
Exome
4
2017
54
0.190
 Why?
Hematologic Neoplasms
1
2023
100
0.180
 Why?
STAT2 Transcription Factor
1
2021
6
0.180
 Why?
STAT1 Transcription Factor
1
2021
27
0.180
 Why?
Germ-Line Mutation
2
2021
66
0.180
 Why?
Li-Fraumeni Syndrome
1
2021
12
0.180
 Why?
Genome-Wide Association Study
3
2018
184
0.180
 Why?
Japan
2
2018
38
0.170
 Why?
Gene Frequency
2
2017
98
0.170
 Why?
Aged, 80 and over
9
2021
3382
0.170
 Why?
Neoplasms
2
2020
1288
0.170
 Why?
Cell Cycle
1
2021
237
0.160
 Why?
Glioblastoma
1
2021
96
0.160
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
 Why?
Leukemia, Plasma Cell
1
2020
33
0.160
 Why?
DNA Methylation
3
2016
583
0.160
 Why?
Ecosystem
1
2021
96
0.160
 Why?
Chromosomal Instability
1
2019
16
0.160
 Why?
Genes, myc
1
2019
39
0.150
 Why?
Chromosomes, Human, Pair 4
3
2014
30
0.150
 Why?
Cell Survival
2
2018
596
0.150
 Why?
Diploidy
2
2017
25
0.150
 Why?
Chromosomes, Human, Pair 11
3
2014
55
0.150
 Why?
INDEL Mutation
1
2018
4
0.140
 Why?
Genes, Tumor Suppressor
2
2021
73
0.140
 Why?
Mutagenesis
1
2018
60
0.140
 Why?
Adult
13
2021
14095
0.140
 Why?
Italy
1
2018
26
0.140
 Why?
Genes, Immunoglobulin Heavy Chain
2
2019
13
0.140
 Why?
Transcriptional Elongation Factors
1
2017
17
0.140
 Why?
Chromosomes, Human, Pair 5
1
2017
17
0.140
 Why?
Histone-Lysine N-Methyltransferase
2
2016
56
0.140
 Why?
Enhancer Elements, Genetic
1
2017
59
0.130
 Why?
Reproducibility of Results
1
2021
1214
0.130
 Why?
Transcriptome
4
2021
363
0.130
 Why?
Melanoma
1
2020
278
0.130
 Why?
Chromosomes, Human
1
2017
41
0.130
 Why?
Hepatocytes
1
2018
190
0.130
 Why?
Immunologic Factors
1
2017
117
0.130
 Why?
B-Lymphocytes
2
2016
180
0.130
 Why?
Neoplasms, Multiple Primary
1
2016
44
0.120
 Why?
Neoplasm Metastasis
1
2016
236
0.120
 Why?
Melphalan
2
2013
178
0.120
 Why?
Oligodendroglioma
1
2015
6
0.120
 Why?
Sequence Analysis, DNA
2
2016
219
0.120
 Why?
ras Proteins
1
2015
63
0.120
 Why?
Endoribonucleases
1
2015
17
0.120
 Why?
Skin Neoplasms
1
2020
499
0.110
 Why?
Survival Rate
4
2020
945
0.110
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
42
0.110
 Why?
Endoplasmic Reticulum Stress
1
2015
49
0.110
 Why?
Survival Analysis
5
2015
667
0.110
 Why?
SMN Complex Proteins
1
2014
4
0.110
 Why?
Signal Transduction
5
2022
1699
0.110
 Why?
RNA Processing, Post-Transcriptional
1
2014
23
0.110
 Why?
Transcription Factors
2
2015
564
0.110
 Why?
Mutation Rate
3
2021
36
0.110
 Why?
Chromosome Deletion
2
2011
139
0.110
 Why?
Cyclin D
1
2013
18
0.110
 Why?
Kaplan-Meier Estimate
4
2018
482
0.110
 Why?
Genes, erbB-1
1
2013
9
0.100
 Why?
Cell Line, Tumor
4
2022
1418
0.100
 Why?
Nerve Tissue Proteins
1
2015
192
0.100
 Why?
RNA, Neoplasm
1
2013
45
0.100
 Why?
Chromosome Breakage
1
2013
16
0.100
 Why?
Repressor Proteins
1
2014
150
0.100
 Why?
Precursor Cells, B-Lymphoid
1
2013
8
0.100
 Why?
Germinal Center
1
2013
30
0.100
 Why?
Retrospective Studies
1
2025
6610
0.100
 Why?
RNA Splicing
3
2021
41
0.100
 Why?
DNA-Binding Proteins
1
2015
424
0.090
 Why?
Genetic Heterogeneity
1
2012
20
0.090
 Why?
Cell Transformation, Neoplastic
1
2013
184
0.090
 Why?
Acetyltransferases
1
2011
18
0.090
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2011
27
0.090
 Why?
Antineoplastic Agents
3
2018
1214
0.090
 Why?
RNA, Messenger
1
2015
1135
0.090
 Why?
Chromosomes, Human, Pair 17
1
2011
35
0.090
 Why?
Cell Proliferation
3
2022
1017
0.090
 Why?
DNA, Neoplasm
3
2018
146
0.090
 Why?
Multivariate Analysis
3
2021
600
0.080
 Why?
TOR Serine-Threonine Kinases
1
2010
82
0.080
 Why?
Remission Induction
2
2021
218
0.080
 Why?
Phenotype
3
2022
794
0.080
 Why?
Tumor Suppressor Protein p53
1
2011
224
0.080
 Why?
Clone Cells
2
2021
76
0.080
 Why?
MicroRNAs
1
2013
385
0.080
 Why?
DNA
1
2012
543
0.070
 Why?
Alleles
2
2021
277
0.070
 Why?
Transcriptional Activation
2
2021
128
0.070
 Why?
Spliceosomes
2
2021
10
0.070
 Why?
Follow-Up Studies
3
2020
2282
0.070
 Why?
Genomic Instability
2
2018
89
0.060
 Why?
Epigenomics
2
2017
74
0.060
 Why?
Risk Factors
3
2021
3922
0.060
 Why?
Loss of Heterozygosity
2
2018
78
0.060
 Why?
Disease-Free Survival
2
2019
462
0.060
 Why?
Treatment Outcome
4
2019
5456
0.060
 Why?
Protein Binding
2
2017
665
0.050
 Why?
Chromosomes, Human, Pair 20
2
2014
11
0.050
 Why?
Liver
2
2022
1154
0.050
 Why?
Genotype
2
2017
563
0.050
 Why?
Dexamethasone
2
2019
435
0.050
 Why?
Histones
2
2016
316
0.050
 Why?
Proportional Hazards Models
2
2015
439
0.050
 Why?
Janus Kinase 1
1
2021
16
0.050
 Why?
Janus Kinase 2
1
2021
26
0.050
 Why?
Nitriles
1
2021
51
0.050
 Why?
Gene Rearrangement
1
2022
76
0.050
 Why?
Organoids
1
2021
39
0.040
 Why?
Microarray Analysis
2
2012
69
0.040
 Why?
Syndecan-1
1
2021
73
0.040
 Why?
Chromosome Mapping
2
2011
149
0.040
 Why?
Polymerase Chain Reaction
2
2013
460
0.040
 Why?
Biomarkers, Pharmacological
2
2011
26
0.040
 Why?
Cell Line
2
2015
1018
0.040
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
68
0.040
 Why?
Pyrazoles
1
2021
113
0.040
 Why?
Cell Movement
1
2022
273
0.040
 Why?
Alternative Splicing
1
2021
61
0.040
 Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
 Why?
Pyrimidines
1
2021
198
0.040
 Why?
Gene Expression
2
2013
618
0.040
 Why?
Phosphoproteins
1
2021
120
0.040
 Why?
Lymphoma, Follicular
1
2020
27
0.040
 Why?
Prospective Studies
2
2016
2424
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
12
0.040
 Why?
Recurrence
1
2021
680
0.040
 Why?
Young Adult
2
2021
4307
0.040
 Why?
Maintenance Chemotherapy
1
2019
50
0.040
 Why?
Syndrome
1
2019
247
0.040
 Why?
Transcription Elongation, Genetic
1
2017
4
0.030
 Why?
Physical Chromosome Mapping
1
2017
7
0.030
 Why?
Genetic Drift
1
2017
3
0.030
 Why?
Gene Knockdown Techniques
1
2018
108
0.030
 Why?
Caspases
1
2018
102
0.030
 Why?
Genetic Loci
1
2017
48
0.030
 Why?
Unfolded Protein Response
1
2017
33
0.030
 Why?
Xenograft Model Antitumor Assays
1
2018
216
0.030
 Why?
Mitosis
1
2017
87
0.030
 Why?
Molecular Targeted Therapy
1
2018
132
0.030
 Why?
Genetic Association Studies
1
2017
123
0.030
 Why?
Genetic Structures
1
2016
1
0.030
 Why?
Risk
1
2017
312
0.030
 Why?
Comparative Genomic Hybridization
1
2016
38
0.030
 Why?
Virus Integration
1
2016
9
0.030
 Why?
Algorithms
1
2020
663
0.030
 Why?
Computational Biology
1
2018
209
0.030
 Why?
Regulatory Sequences, Nucleic Acid
1
2016
43
0.030
 Why?
Nuclear Proteins
1
2017
246
0.030
 Why?
Flow Cytometry
1
2017
397
0.030
 Why?
Tumor Microenvironment
1
2017
246
0.030
 Why?
Immunosuppressive Agents
1
2017
249
0.030
 Why?
Minor Histocompatibility Antigens
1
2015
18
0.030
 Why?
Antibodies, Monoclonal
1
2019
475
0.030
 Why?
MafB Transcription Factor
1
2015
9
0.030
 Why?
Proto-Oncogene Proteins c-maf
1
2015
19
0.030
 Why?
Cytidine Deaminase
1
2015
12
0.030
 Why?
RNA Stability
1
2015
24
0.030
 Why?
Patient Selection
1
2016
265
0.030
 Why?
Amino Acid Sequence
1
2016
566
0.030
 Why?
Chromosomes, Human, Pair 16
1
2014
18
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2015
53
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2014
12
0.030
 Why?
Cytogenetic Analysis
1
2014
79
0.030
 Why?
Ribonucleoproteins, Small Nuclear
1
2014
5
0.030
 Why?
Time Factors
1
2021
2970
0.030
 Why?
Introns
1
2014
53
0.030
 Why?
Single-Cell Analysis
1
2014
71
0.030
 Why?
Methylation
1
2014
126
0.030
 Why?
Protein Isoforms
1
2014
124
0.030
 Why?
Base Sequence
1
2015
627
0.030
 Why?
Down-Regulation
1
2015
343
0.030
 Why?
High-Throughput Screening Assays
1
2013
37
0.030
 Why?
Molecular Sequence Data
1
2015
766
0.030
 Why?
Protein Structure, Tertiary
1
2014
252
0.030
 Why?
HeLa Cells
1
2014
242
0.030
 Why?
Osteonectin
1
2013
10
0.030
 Why?
Chromosomes, Human, Pair 7
1
2013
29
0.030
 Why?
Karyotyping
1
2013
78
0.030
 Why?
Azacitidine
1
2013
39
0.030
 Why?
Transforming Growth Factor beta1
1
2013
62
0.020
 Why?
Mass Spectrometry
1
2014
293
0.020
 Why?
Homologous Recombination
1
2013
41
0.020
 Why?
Disease Models, Animal
1
2018
1467
0.020
 Why?
Early Detection of Cancer
1
2014
183
0.020
 Why?
Apoptosis
1
2018
1117
0.020
 Why?
Validation Studies as Topic
1
2012
10
0.020
 Why?
Tumor Suppressor Proteins
1
2013
128
0.020
 Why?
Gene Library
1
2012
42
0.020
 Why?
Laboratories
1
2012
20
0.020
 Why?
Hemizygote
1
2011
6
0.020
 Why?
Predictive Value of Tests
1
2014
939
0.020
 Why?
Animals
2
2018
13332
0.020
 Why?
Drug Resistance, Neoplasm
1
2013
324
0.020
 Why?
Breast Neoplasms
1
2020
1199
0.020
 Why?
Bone Marrow
1
2013
361
0.020
 Why?
Vincristine
1
2010
88
0.020
 Why?
Prednisolone
1
2010
56
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
411
0.020
 Why?
Adolescent
1
2021
6681
0.020
 Why?
Cluster Analysis
1
2010
236
0.020
 Why?
Precancerous Conditions
1
2010
85
0.020
 Why?
Cyclophosphamide
1
2010
173
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
136
0.020
 Why?
Clinical Trials as Topic
1
2012
463
0.020
 Why?
Stem Cell Transplantation
1
2010
186
0.020
 Why?
Child
1
2021
7147
0.020
 Why?
Models, Biological
1
2012
731
0.020
 Why?
Doxorubicin
1
2010
242
0.020
 Why?
Sex Factors
1
2011
731
0.020
 Why?
Up-Regulation
1
2010
459
0.020
 Why?
Risk Assessment
1
2013
1339
0.020
 Why?
Prevalence
1
2011
1013
0.020
 Why?
Mice
1
2018
5877
0.020
 Why?
Wardell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (266) concept(s)
_
Co-Authors Expand Description
See all (31) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department